Optimal drug therapy for glucose intolerance is a pledge of successful prevention of type 2 diabetes mellitus

被引：0
|
作者：
Mkrtumyan, AM [1 ]
机构：
[1] IM Sechenov Med Acad, Dept Postgrad Med Educ, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2002年 / 74卷 / 12期
关键词：
lecture; diabetes mellitus; drug therapy for glucose intolerance; glucobay;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：86 / 89
页数：4
相关论文
共 50 条
  • [21] Prevention of diabetes mellitus type 2
    Soriguer, Federico
    Rubio-Martin, Elehazara
    Rojo-Martinez, Gemma
    MEDICINA CLINICA, 2012, 139 (14): : 640 - 646
  • [22] The prevention of type 2 diabetes mellitus
    Inzucchi, SE
    Sherwin, RS
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2005, 34 (01) : 199 - +
  • [23] Glycerolemia as a predictor of glucose intolerance and type 2 diabetes
    Gaudet, D
    Perron, P
    St-Pierre, J
    Brisson, D
    Rioux, JD
    Vohl, MC
    Hudson, TJ
    DIABETES, 2004, 53 : A271 - A271
  • [24] Profile of glucose lowering drug use in outpatients with type 2 diabetes mellitus
    Grassi, Bruno A.
    Hernandez, Camila
    Boncompte, Mariana
    Henriquez, Camila
    L'Huilliera, Nicole
    Miranda, Francisca
    Vrsalovic, Katica
    Rosales, Valentina
    REVISTA MEDICA DE CHILE, 2022, 150 (10) : 1334 - 1341
  • [25] A new drug-modifying therapy for Type 2 Diabetes Mellitus
    Roesti, E. S.
    Boyle, C. N.
    Meier, D. T.
    Sande-Melon, M.
    Vogel, M.
    Bachmann, M. F.
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [26] Optimizing drug therapy in frail patients with type 2 diabetes mellitus
    Molist-Brunet, N.
    Sevilla-Sanchez, D.
    Puigoriol-Juvanteny, E.
    Gonzalez-Bueno, J.
    Sola-Bonada, N.
    Cruz-Grullon, M.
    Espaulella-Panicot, J.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (08) : 1551 - 1559
  • [27] Optimizing drug therapy in frail patients with type 2 diabetes mellitus
    N. Molist-Brunet
    D. Sevilla-Sánchez
    E. Puigoriol-Juvanteny
    J. González-Bueno
    N. Solà- Bonada
    M. Cruz-Grullón
    J. Espaulella-Panicot
    Aging Clinical and Experimental Research, 2020, 32 : 1551 - 1559
  • [28] Optimal drug therapy in patients with type 2 diabetes mellitus and coronary artery disease-Update 2021
    Edel, Klaus
    Mootz, Ralf
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2021, 35 (04): : 201 - 210
  • [29] Effects of statins on progression of glucose intolerance and diastolic dysfunction in a model of type-2 diabetes mellitus
    Koji, O
    Yan, C
    Kaorv, S
    Junji, Y
    Norihiro, F
    Katsufumi, M
    Hiroaki, K
    Masakazu, K
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S163 - S163
  • [30] Prevalence of type 2 diabetes mellitus and glucose intolerance among persons with chronic liver diseases in Mongolia
    Jambaljav, B.
    Tuul, N.
    Suvdaa, J.
    Tsetsgee, D.
    Yanjmaa, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 86 - 86
12345